ESMO Virtual Congress 2020, 19-21 September
The ESMO Congress 2020 will be held as a virtual meeting, with the programme delivered over two weekends:
- Science weekend on 19-21 September
- Educational weekend on 16-18 October
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The ESMO Congress 2020 will be held as a virtual meeting, with the programme delivered over two weekends:
Artificial intelligence (AI) holds promise for enabling earlier detection of pancreatic cancer, which is crucial to saving lives. The potential of AI is showcased in a study to be presented at the ESMO World Congress on Gastrointestinal Cancer, 1-4 July 2020.
The ESMO World Congress on Gastrointestinal Cancer 2020 will be held as a virtual meeting, on 1-4 July.
ESMO, the leading professional organisation for medical oncology, has today announced the appointment of Professor George Pentheroudakis MD PhD as its new Chief Medical Officer (CMO).
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment.
Cancer-related fatigue is a prevalent and potentially persistent issue among breast cancer survivors, which can prevent them from returning to their previous life well after treatment ends and they are declared free of disease.
The 2020 ESMO Breast Cancer Congress will be held as a virtual meeting, on 23-24 May.
Death rates from prostate cancer are predicted to fall in 2020 in the EU, according to new research published in the journal Annals of Oncology.
Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers.
Researchers have developed the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease.
A growth hormone called IGF-1 is likely to play a role in the development of breast cancer, according to new research published in Annals of Oncology.
International Women’s Day: ESMO supports women in South Africa to become autonomous workers.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.